Introduction
The human genome project (HGP) provided important information about structure, organization and predicted function of 2.85 billion nucleotides in the DNA sequence, which is the foundation for biomedical research, genetic diagnosis and evolutionary genomics [1] . However, the genetic basis of complex disorders as diabetes, cardiovascular diseases, Alzheimer, schizophrenia, autoimmune diseases and cancer, remains unclear.
The multifactorial nature of these diseases involves an intricate gene network and environmental influences that reprogram the genome and hinders the knowledge of the mechanisms involved in its pathophysiology. The environment affects the epigenetic mechanisms that control gene function, without changing the DNA sequence, leading to altered gene expression and disruption of many biological processes. Unlike the genome, the epigenome can be reprogramed and have great plasticity. Epigenetic reprogramming is the main event during cell differentiation, conferring structural and functional differences of a given cell type (phenotype) that is mitotically inheritable ensuring a tissue-specific gene expression.
This phenomenon was first described by Conrad Waddington
(1942) in studies of the "Canalization of development", in which an organism's genotype responds to the environment in a coordinated manner, in a genotype-genotype and genotype-environment interaction, and this response can be fixed independently of mutational effects [2] . Epigenetic modifications regulate crucial biological process in mammalian development such as genomic imprinting and X-chromosome inactivation (XCI), as well as maintenance of genomic stability and inactivation of repetitive DNA elements [3] . Changes in the establishment or maintenance of epigenetic modifications lead to the development of several human diseases [4, 5] . Genomic imprinting, a monoallelic gene expression depending on parental origin, is essential for proper embryo growth and development. Loss of genomic imprinting (LOI) is related to developmental disorders, such as Beckwith-Wiedemann (BWS), Silver-Russell, Prader-Willi and Angelman syndromes [6] .
Biallelic expression of imprinted genes has been implicated
in the pathogenesis of several complex diseases, such as diabetes mellitus, autism, bipolar disorder, schizophrenia and cancer [7] .
The main mechanism that controls the monoallelic expression of imprinted genes is DNA methylation. The imprinting control regions (ICRs) are differentially methylated (DMR) depending on the parental origin [6, 7] . DNA methylation is a repressive epigenetic mark characterized by the covalent addition of a methyl group (-CH3) at the carbon-5 position of cytosine-phosphate-guanine dinucleotide (CpG) generating 5-methylcytosine (5mC) ( Figure 1A ) [3] . (TET) family that oxidize 5mC to produce 5-hydroxymethylcytosine (5-hmC) [8] . DNA methylation can also happens in adenine resides, the N6-methyladenine DNA modification (N6-mA), however, its role in human diseases remain unclear [9] . Usually, mammalian genomes are mostly hypermethylated in non-CpG rich domains (CpG islands), such as promoter and regulatory regions, where the methylation pattern is variable and the hypermethylation at those regions are responsible for gene silencing or reduction of its activity.
Hypomethylation of proto-oncogenes and hypermethylation of tumor suppressor genes contribute to cancer development. It has been suggested that aberrant epigenetic reprogramming seems to be the key event that initiates and propagates the carcinogenesis process [10] . DNA methylation is also responsible for the maintenance of genomic stability and silencing of transposable elements [3] .
DNA methylation also plays an important role in the maintenance of XCI, an epigenetic process by which one of the copies of the X chromosome in the female genome is inactivated. This is a random process with an equal proportion of cells expressing either the maternal or paternal allele, as a dosage compensation mechanism between parental genomes [11] . Skewed XCI is related to X-linked disorders and reproductive alterations, like premature ovarian insufficiency [12] . The main mechanism which controls the XCI and histone deacetylases (HDACs) ( Figure 1B) , and methylation, as histone methyltransferases (HMTs) and demethylases (HDMs).
Nonetheless, PTMs are a complex event and other enzymes may be involved, especially in the methylation modification [18] . 
